Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud ...

As reproductive rights are destroyed and female journalists are told to be “quiet, piggy” by the US president, is it a ...

Danish pharmaceutical company Novo Nordisk has launched its blockbuster diabetes and weight-related therapy Ozempic in India, ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

A new Pew Research Center survey of 1,458 teens between the ages of 13 and 17 found that 64 percent have used an AI chatbot, ...

Neuroplasticity research shows that maternal brains are rewired for immense creativity and problem solving. How could GLP-1s ...

Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...

Novo Nordisk A/S (NYSE:NVO) is one of the best pharma stocks to invest in. Argus analyst Jasper Hellweg downgraded Novo ...